RPS15A and pancreatic neoplasm: Inhibition of RPS15A by miR-519d-3p leads to the down-regulation of Wnt/β-catenin pathway in pancreatic cancer which proves the potential role of RPS15A as a target to treat pancreatic cancer [101].